What Is The Current and Historic Market Size Analysis Of The Vagus Nerve Stimulation Market?
The vagus nerve stimulation market has seen considerable growth due to a variety of factors.
• Recent years have seen a swift expansion in the market size for vagus nerve stimulation. The market, which stood at $0.89 billion in 2024, is projected to expand to $1.02 billion in 2025, marking a compound annual growth rate (CAGR) of 14.9%.
This exceptional growth during the historical period is likely due to several factors including an upsurge in the elderly population, high occurrence of depression, increasing awareness and acceptance of alternative treatment methods, a rise in epilepsy cases, and a surge in chronic disease incidence.
What Are The Predictions for The Vagus Nerve Stimulation Market in the Coming Years?
The vagus nerve stimulation market is expected to maintain its strong growth trajectory in upcoming years.
• Over the coming years, the vagus nerve stimulation market is projected to experience exponential growth, expanding to a value of $1.76 billion in 2029, with a compound annual growth rate (CAGR) of 14.6%.
A surge in treatment-resistant depression, the escalating adoption of minimally invasive neurosurgical procedures, increasing research and development (R&D) efforts, enhanced healthcare infrastructure, and a rising frequency of neurological disorders, are all contributing to the growth in this forecast period. The projected trends in this period include technological progress, innovations in product design, the advent of robot-assisted implantation, advancements in electrical stimulation devices, and novel stimulation techniques.
Which Drivers Are Accelerating Growth In The Vagus Nerve Stimulation Market?
The rise in neurological disorders is anticipated to boost the vagus nerve stimulation market's expansion. Neurological disorders, which impact the brain, spinal cord, or nerves and result in issues with movement, sensation, cognition, or general function, are becoming more prevalent. These disorders can stem from a mixture of genetic, environmental, and lifestyle factors, while physical injuries, like head and spinal cord injuries, can also cause neurological issues. Vagus nerve stimulation is employed to treat these disorders as it influences brain activity and neurotransmitter levels, thus aiding in minimizing symptoms in conditions like epilepsy, depression, and certain types of migraines. For example, the Australian Institute of Health and Welfare, a government agency based in Australia, estimated that, in September 2024, 411,100 Australians had dementia in 2023, a number expected to more than double by 2058. Consequently, this surge in neurological disorders is pushing the vagus nerve stimulation market forward.
What Are The Core Segments Of The Global Vagus Nerve Stimulation Market?
The vagus nerve stimulation market covered in this report is segmented –
1) By Product: Implantable Vagus Nerve Stimulation Device, External Vagus Nerve Stimulation Device
2) By Biomaterial: Metallic, Ceramics, Polymeric
3) By Application: Epilepsy, Depression, Migraine
4) By End-Use: Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers
Subsegments:
1) By Implantable Vagus Nerve Stimulation Device: Pulse Generators, Leads and Electrodes, Rechargeable Implantable Devices, Non-Rechargeable Implantable Devices
2) By External Vagus Nerve Stimulation Device: Transcutaneous Vagus Nerve Stimulation Devices, Wearable VNS Devices, Portable External Stimulators, Home-use VNS Devices
Pre-Book The Vagus Nerve Stimulation Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Vagus Nerve Stimulation Market?
Key businesses in the vagus nerve stimulation market are striving to create technologically superior products, such as implantable pulse generators (IPG). These IPGs offer long-lasting, adjustable and targeted treatment for chronic ailments. An IPG, a medical tool planted surgically beneath the skin, provides electrical pulses to designated parts of the body to manage conditions like chronic pain or neurological disorders. For example, in February 2023, medical device firm LivaNova Plc, headquartered in the UK, introduced the SenTiva DUO. This unique IPG device is specifically designed for vagus nerve stimulation therapy, aimed at treating drug-resistant epilepsy. The innovative device offers patients with older dual-pin systems the opportunity to upgrade without the need for lead revisions. It delivers state-of-the-art VNS therapy with customizable, automatic delivery, improves seizure control and encourages optimal treatment adherence. Thus, the SenTiva DUO represents a major breakthrough for individuals seeking efficient control over their condition.
Who Are the Key Players In The Vagus Nerve Stimulation Market?
Major companies operating in the vagus nerve stimulation market are:
• Medtronic PLC
• Stryker Corporation
• Boston Scientific Corporation
• Dignity Health
• LivaNova LLC
• NeuroTek Inc.
• Neurospace Inc.
• ReShape Lifesciences Inc.
• electroCore Inc.
• Adriakaim Inc.
• Soterix Medical Inc.
• Nexstim PLC
• Cleveland Medical Devices Inc.
• MicroTransponder Inc.
• Parasym Ltd.
• Neuvana LLC
• NeuroSigma Inc.
• Evren Technologies Inc.
• Integrative Health Technologies Inc.
• Aucta Technologies Inc
What Are The Regional Insights Into The Vagus Nerve Stimulation Market?
North America was the largest region in the vagus nerve stimulation market in 2024. The regions covered in the vagus nerve stimulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
